InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+1.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Lenz Brian, Chief Financial Officer. Officer active across 1 company, notably Adma Biologics, INC.. Aggregated, 17 disclosures have been recorded. Split: 2 buys · 1 sell. Total volume traded: €937k. History available since 29 September 2021. The latest transaction was filed on 6 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lenz Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
16,677 shares@ US$6.124.5% of flowCommon StockSEC:0001140361-24-012446:0
4,935 shares@ US$5.361.2% of flowCommon StockSEC:0001140361-24-011193:0
8,257 shares@ US$5.261.9% of flowCommon StockSEC:0001140361-24-009843:0
16,908 shares@ US$4.523.3% of flowCommon StockSEC:0001140361-24-001139:0
15,268 shares@ US$3.582.5% of flowCommon StockSEC:0001140361-23-046742:0
211,578 shares@ US$4.597543.2% of flowCommon StockSEC:0001140361-23-040321:0
15,268 shares@ US$3.692.5% of flowCommon StockSEC:0001140361-23-033191:0
15,469 shares@ US$3.312.3% of flowCommon StockSEC:0001140361-23-016460:0
1,559 shares@ US$3.420.2% of flowCommon StockSEC:0001140361-23-010773:0
114,222 shares@ US$3.8720.3% of flowCommon StockSEC:0001140361-23-000872:0
6,993 shares@ US$2.860.9% of flowCommon StockSEC:0001140361-22-045112:0
Canonical exit: 9 Mar 2023 (T+90)
73,678 shares@ US$2.438.8% of flowCommon StockSEC:0001140361-22-036163:0
51,965 shares@ US$1.433.5% of flowCommon StockSEC:0001140361-22-019216:0
37,178 shares@ US$1.462.4% of flowCommon StockSEC:0001140361-22-011251:0
137,500 shares0Common StockSEC:0001140361-22-008673:0
30,000 shares@ US$1.001.3% of flowCommon StockSEC:0001140361-21-035380:0
Canonical exit: 23 Jan 2022 (T+90)
495,000 shares0Common StockSEC:0001140361-21-033355:0
17 of 17 declarations
About Lenz Brian
LENZ BRIAN is Directeur Financier and EVP, CFO at Adma Biologics, INC. The 17 filings on record cover the period from 2021-10-01 to 2024-03-08, and in this recent sample the reported amounts are EUR 44776 of buys and EUR 892071 of sells. The most frequent transaction nature is Retenue fiscale.
